![](/img/cover-not-exists.png)
A Phase I/II Trial of Carfilzomib, Pegylated Liposomal Doxorubicin, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma
Schroeder, Mark A., Fiala, Mark A, Huselton, Eric, Cardone, Michael H, Jaeger, Savina, Jean, Sae Rin, Shea, Kathryn, Ghobadi, Armin, Wildes, Tanya, Stockerl-Goldstein, Keith E, Vij, RaviLanguage:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-18-1909
Date:
April, 2019
File:
PDF, 1.77 MB
english, 2019